DeepQure
Latest round
- Series C
Last raised
- Apr 2025
Total raised
- Undisclosed
Investors
- 1
About DeepQure
DeepQure Inc.DeepQure Inc. specializes in renal denervation technology aimed at treating hypertension. Founded in 2019 in Seoul, South Korea, the company has maintained its focus on advancing hypertension care without notable pivots in strategy. The founder's previous entrepreneurial history is not disclosed.DeepQure Inc. is focused on addressing the significant global health challenge of hypertension through its innovative HyperQure RDN System. This flagship product is a laparoscopic-based renal denervation (RDN) device designed to provide a minimally invasive non-drug treatment option for hypertension, particularly for patients with resistant hypertension. The device works by ablating nerves in the renal arteries, which is intended to effectively lower blood pressure and reduce the risk of serious complications associated with uncontrolled hypertension. Targeting a client base that includes healthcare providers and hospitals, specifically those in regions with high incidences of hypertension such as North America, Europe, and parts of Asia, DeepQure aims to offer a viable alternative to traditional medication regimens.DeepQure’s revenue generation model primarily revolves around partnerships with healthcare institutions and direct sales of its HyperQure RDN System. The company engages in transactions with hospitals and clinics that are looking to implement advanced treatments for hypertension, facilitating a direct-to-consumer approach through medical professionals. Specific pricing details are tailored to meet the needs of these institutions, allowing for a flexible transaction structure that could include bulk purchases or service contracts for ongoing support and maintenance of the RDN devices. Given the critical nature of hypertension treatment, DeepQure's offerings are positioned as essential additions to the portfolios of medical facilities seeking to enhance their treatment capabilities.In April 2025, DeepQure Inc. Plans for new product developments and entry into specific markets are in progress, although details on exact timelines or additional product launches have not been disclosed.
Who invested in DeepQure
1 investor across 2 rounds
See all investors in DeepQure
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DeepQure
Who invested in DeepQure?
DeepQure has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DeepQure raised?
DeepQure has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did DeepQure last raise money?
DeepQure's most recent round on record is a Series C, in Apr 2025.
What does DeepQure do?
DeepQure is a medical devices & equipment company.
Where is DeepQure headquartered?
DeepQure is headquartered in Seoul, South Korea.
Which VCs invest in companies like DeepQure?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at DeepQure's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like DeepQure? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.